(0.27%) 5 113.98 points
(0.29%) 38 352 points
(0.29%) 15 974 points
(-0.94%) $83.06
(5.51%) $2.03
(0.37%) $2 355.90
(0.44%) $27.66
(3.99%) $958.85
(-0.22%) $0.933
(-0.41%) $10.98
(-0.55%) $0.796
(1.69%) $93.43
Live Chart Being Loaded With Signals
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide...
Stats | |
---|---|
本日の出来高 | 18 515.00 |
平均出来高 | 759 938 |
時価総額 | 9.94M |
EPS | $0 ( 2024-04-02 ) |
次の収益日 | ( $-0.140 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.200 |
ATR14 | $0.00100 (0.30%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-17 | Esser Eric Eugene | Buy | 200 000 | Stock Option (right to buy) |
2024-04-17 | Esser Eric Eugene | Buy | 100 000 | Common Stock |
2023-06-22 | Nelson Todd Robert | Buy | 385 500 | Stock Option (right to buy) |
2023-06-22 | Nelson Todd Robert | Buy | 47 700 | Common Stock |
2024-03-01 | Nelson Todd Robert | Sell | 4 756 | Common Stock |
INSIDER POWER |
---|
95.80 |
Last 89 transactions |
Buy: 85 527 522 | Sell: 75 379 307 |
ボリューム 相関
Translate Bio Inc 相関
10 最も負の相関 | |
---|---|
DRNA | -0.948 |
SUMO | -0.941 |
OCSL | -0.925 |
CMPI | -0.908 |
ALBO | -0.906 |
MIGI | -0.895 |
IMAQ | -0.893 |
TCBC | -0.892 |
ZIONP | -0.89 |
XM | -0.89 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Translate Bio Inc 相関 - 通貨/商品
Translate Bio Inc 財務諸表
Annual | 2023 |
収益: | $27.51M |
総利益: | $12.85M (46.70 %) |
EPS: | $-1.600 |
FY | 2023 |
収益: | $27.51M |
総利益: | $12.85M (46.70 %) |
EPS: | $-1.600 |
FY | 2022 |
収益: | $27.44M |
総利益: | $15.60M (56.84 %) |
EPS: | $-1.650 |
FY | 2020 |
収益: | $138.81M |
総利益: | $0.00 (0.00 %) |
EPS: | $-1.046 |
Financial Reports:
No articles found.
Translate Bio Inc
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。